(c) 2024 PillSync.com

vylibra norgestimate 0.25 mg ethinyl estradiol 0.035 mg

1 INDICATIONS AND USAGE VyLibra is estrogen/progestin COCs, indicated for use by women to prevent pregnancy. (1.1) 1.1 Oral Contraceptive VyLibra tablets are indicated for use by females of reproductive potential to prevent pregnancy [see Clinical Studies (14) ] .

afaxys pharma, llc


6 months ago ROUND BLUE 22 S vylibra norgestimate 0.25 mg ethinyl estradiol 0.035 mg

ROUND BLUE 22 S

6 months ago ROUND BLUE 22 S vylibra norgestimate 0.25 mg ethinyl estradiol 0.035 mg

22 S ROUND BLUE

16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied VyLibra (

NORGESTIMATE AND ETHINYL ESTRADIOL tablets USP 0.250 mg/0.035 mg) are available in a blister pack. Each blister pack (28 tablets) contains in the following order: 21 dark blue, round, biconvex, coated tablet debossed with ā€œSā€ on one side and ā€œ22ā€ on other side of the tablet contains 0.250 mg norgestimate and 0.035 mg ethinyl estradiol 7 green round, mottled, biconvex, uncoated tablets, debossed with ā€œSā€ on one side and ā€œ24ā€ on other side of the tablet contains inert ingredients The blister packs are available in the following packages: The Blister Packs are packaged in mono cartons Carton of 1 Blister Pack NDC 50102-235-11 Carton of 3 Blister Packs packaged in mono cartons NDC 50102-235-13 16.2 Storage Conditions Store at 20Ā° to 25Ā°C (68Ā° to 77Ā°F) [see USP Controlled Room Temperature]. Protect from light. Keep out of the reach of children.


More pills like ROUND 22 S

Related Pills

Bupropion Hydrochloride 100 mg

Solco Healthcare US LLC












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site